- Messages
- 94
- Location
- Netherlands
from the video:
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an alternative browser.
You should upgrade or use an alternative browser.
Dr. Jarred Younger - updates
- Thread starter Sasha
- Start date
- Messages
- 94
- Location
- Netherlands
Of course he says that you shouldn't try these, but many I've seen people trying here.
- Messages
- 94
- Location
- Netherlands
The Open Medicine Foundation (OMF) has started a clinical trial of low dose naltrexone (LDN) and pyridostigmine bromide (Mestinon) for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
- Messages
- 94
- Location
- Netherlands
My CRP has been pretty consistently 0,8 mg/l, so that means 0,08 a mg/dl like here right? which seems very low. Curious to see the video on me/cfs hopefully next week.
1l = 10dl so that should check outMy CRP has been pretty consistently 0,8 mg/l, so that means 0,08 a mg/dl like here right? which seems very low. Curious to see the video on me/cfs hopefully next week.
- Messages
- 94
- Location
- Netherlands
note his comment: "ERROR: The hs-CRP values I show in this video are in mg/L units (not mg/dL as I claimed). I will look over the videos and see if I need to remove them or reupload with notes added. For now, just note that all values I mention are actually mg/L, which is what you are most likely to see from your clinic or hospital anyway. Sorry for the mixup! - Jarred Younger"
- Messages
- 94
- Location
- Netherlands
Does anyone know if there's something going on with Dr. Younger? He hasn't posted a video in over a month.
- Messages
- 94
- Location
- Netherlands
Important research, also the short remark.about the subgroups is very interesting and I hope we get proper research into just that. Good to see him back, I was worried.
most interesting to me was how it could explain how PEM works: a brain already struggling with too much lactate gets overwhelmed with even more lactate after exertion (through dysfunctional blood–brain barrier)Important research, also the short remark.about the subgroups is very interesting and I hope we get proper research into just that. Good to see him back, I was worried.